[Nasolacrimal duct disorders in children. Part II. Treatment]

Danuta Sielicka1, Małgorzata Mrugacz, Alina Bakunowicz-Łazarczyk

  • 1Z Kliniki Okulistyki Dzieciecej z Ośrodkiem Leczenia Zeza, Uniwersyteckiego Dzieciecego Szpitala Klinicznego w Białymstoku.

Klinika Oczna
|April 9, 2011
PubMed

Insights

Congenital nasolacrimal duct obstruction (CLDO) affects over 5% of infants, causing eye discharge. While many cases resolve spontaneously, treatments like probing, intubation, or surgery may be needed for persistent symptoms.

Area of Science:

  • Ophthalmology
  • Pediatric Medicine
  • Anatomy

Background:

  • Congenital nasolacrimal duct obstruction (CLDO) is a frequent infant disorder, impacting over 5% of newborns.
  • Symptoms include epiphora and mucous discharge, typically appearing within the first weeks of life.

Purpose of the Study:

  • To review the diagnostic and therapeutic approaches for congenital nasolacrimal duct obstruction.

Main Methods:

  • Conservative management: lacrimal sac massage, topical antibiotics for secondary infections.
  • Surgical interventions: nasolacrimal duct probing, intubation, balloon catheter dilatation, laser endoscopic dacryocystorhinostomy, endonasal endoscopic dacryocystorhinostomy (EESC-DCR), and external dacryocystorhinostomy (EXT-DCR).

Main Results:

  • Most CLDO cases resolve spontaneously.
  • Prognosis for probing decreases with increased attempts and patient age.
  • Advanced surgical techniques are available for refractory cases.

Conclusions:

  • CLDO management ranges from conservative measures to surgical interventions.
  • The choice of treatment depends on obstruction severity, patient age, and prior treatment outcomes.